Xencor (XNCR) Capital Expenditures (2013 - 2026)
Xencor's (XNCR) quarterly Capital Expenditures came in at $610000.0 in Q1 2026, down 57.76% year-on-year from $1.4 million in Q1 2025, and down 46.49% on a QoQ basis from $1.1 million in Q4 2025.
Xencor (XNCR) Capital Expenditures (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Capital Expenditures data on file, last reported at $610000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 57.76% year-over-year to $610000.0 in Q1 2026; TTM through Mar 2026 was $2.3 million, a 68.74% decrease from a year earlier, with the FY2025 full-year figure at $3.2 million, down 48.34% from the prior year.
- Capital Expenditures for Q1 2026 stood at $610000.0, down from $1.1 million in the prior quarter.
- Over the last five years, Capital Expenditures for XNCR reached as high as $14.1 million in Q3 2022 and fell as low as $132000.0 in Q1 2024.
- Historically, Capital Expenditures has averaged $3.9 million across 5 years, with a median of $1.7 million in 2024.
- Across the five-year window, Capital Expenditures plunged 98.78% in 2024 and surged 993.94% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at $10.0 million in 2022, then plunged by 90.17% to $980000.0 in 2023, then jumped by 69.8% to $1.7 million in 2024, then tumbled by 31.49% to $1.1 million in 2025, then plunged by 46.49% to $610000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $610000.0 in Q1 2026, $1.1 million in Q4 2025, and $183000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 610,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 610,000.00 |
| Mar 31, 2026 | 610,000.00 |
| Dec 31, 2025 | 1.14 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 183,000.00 |
| Sep 30, 2025 | 183,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Mar 31, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Mar 31, 2024 | 132,000.00 |
| Mar 31, 2024 | 132,000.00 |
| Dec 31, 2023 | 980,000.00 |
| Dec 31, 2023 | 980,000.00 |